Eventually, the team of Dow and Sangamo scientists showed that it could
engineer zinc finger nucleases that gave a two - for - one deal.
Dow Agrosciences wanted to see if
engineered zinc finger nucleases could speed up genetic engineering.
Not exact matches
By using
engineered zinc -
finger nucleases (ZFNs) designed to target an integrated reporter and two endogenous rat genes, Immunoglobulin M (IgM) and Rab38, we demonstrate that a single injection of DNA or messenger RNA encoding ZFNs into the one - cell rat embryo leads to a high frequency of animals carrying 25 to 100 % disruption at the target locus.
Talk of curing AIDS made front - page news last year, in part due to an astonishing new gene - editing technology: lab -
engineered proteins called
zinc finger nucleases.
Here we describe
engineering a pair of
zinc finger nucleases that, when introduced into human T cells, efficiently disrupt cxcr4 by cleavage and error - prone non-homologous DNA end - joining.
Previously we
engineered zinc -
finger nucleases (ZFNs) to specifically disrupt the CCR5 gene in primary human T cells, the predominant cell type infected and killed by HIV.
Working with proteins called
zinc finger nucleases and TALENs, Zhang attempted to edit the genomes of mammalian cells with a view to
engineering them.
With the genome
engineering revolution came epigenome -
engineering tools -
zinc finger nucleases and TALENs fused to epigenetic modifiers enabled epigenetic modifications at a user - specified locus.